Washington University School of Medicine (WashU Medicine) researchers have developed an Alzheimer’s blood test symptom prediction model that estimates when individuals may begin to show signs of the disease.

This new approach can forecast symptom onset within a three to four-year window.

The study was part of a project initiated by the Foundation for the National Institutes of Health Biomarkers Consortium. WashU Medicine is a member of this public-private partnership.